UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.580

Sortiert nach

Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5542-5551

2005

Volltextzugriff (PDF)

Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer

Oncogene, 2010-03, Vol.29 (9), p.1339-1350

2010

Volltextzugriff (PDF)

In search of fundamental discreteness in (2 + 1)-dimensional quantum gravity

Classical and quantum gravity, 2009-09, Vol.26 (18), p.185011-185011 (26)

2009

Volltextzugriff (PDF)

Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study

Journal of clinical oncology, 1998-03, Vol.16 (3), p.994-999

1998

Volltextzugriff (PDF)

The effective kinetic term in CDT

Journal of physics. Conference series, 2012-01, Vol.360 (1), p.12038-4

Budd, T G

2012

Volltextzugriff (PDF)

Semi-classical dynamical triangulations

Physics letters. B, 2012-11, Vol.718 (1), p.200-204

2012

Volltextzugriff (PDF)

Phase I Trial of Exisulind (Sulindac Sulfone, FGN-1) as a Chemopreventive Agent in Patients with Familial Adenomatous Polyposis

Clinical cancer research, 2000-01, Vol.6 (1), p.78-89

2000

Volltextzugriff (PDF)

Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy

Clinical cancer research, 1998-10, Vol.4 (10), p.2337-2347

1998

Volltextzugriff (PDF)

Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumors

Cancer, 1997-09, Vol.80 (6), p.1134-1140

1997

Volltextzugriff (PDF)

Estrogen receptor mutations in tamoxifen-resistant breast cancer

Cancer research (Chicago, Ill.), 1994-01, Vol.54 (2), p.349-353

1994

Volltextzugriff (PDF)

Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706

Leukemia, 2005-11, Vol.19 (11), p.1880-1886

2005

Volltextzugriff (PDF)

Phase II trial of liposomal doxorubicin (Doxil®) in advanced soft tissue sarcomas

Investigational new drugs, 2000-08, Vol.18 (3), p.253-259

2000

Volltextzugriff (PDF)

A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinoma

Investigational new drugs, 2002-08, Vol.20 (3), p.305-310

2002

Volltextzugriff (PDF)

Interferon-γ and CXC chemokine induction by interleukin 12 in renal cell carcinoma

Clinical cancer research, 1999-10, Vol.5 (10), p.2780-2789

1999

Volltextzugriff (PDF)

Amifostine and chemotherapy-related thrombocytopenia

Seminars in oncology, 1996-08, Vol.23 (4), p.49-52

BUDD, G. T

1996

Volltextzugriff (PDF)

Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma

Journal of cancer research and clinical oncology, 2001-05, Vol.127 (5), p.319-324

2001

Volltextzugriff (PDF)

Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study

Journal of clinical oncology, 1995-04, Vol.13 (4), p.831-839

1995

Volltextzugriff (PDF)

Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma

Cancer research (Chicago, Ill.), 1991-08, Vol.51 (16), p.4199-4205

1991

Volltextzugriff (PDF)

Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial

Journal of clinical oncology, 1988-05, Vol.6 (5), p.880-888

1988

Volltextzugriff (PDF)

Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trial

Journal of clinical oncology, 1997-07, Vol.15 (7), p.2494-2501

1997

Volltextzugriff (PDF)

Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancy

Journal of clinical oncology, 1992-05, Vol.10 (5), p.804-809

1992

Volltextzugriff (PDF)

Ifosfamide in the treatment of soft tissue sarcomas

Seminars in oncology, 1996-06, Vol.23 (3), p.16-21

1996

Volltextzugriff (PDF)

Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects

Journal of clinical oncology, 1994-01, Vol.12 (1), p.97-106

1994

Volltextzugriff (PDF)

Palliative chemotherapy of adult soft tissue sarcomas

Seminars in oncology, 1995-04, Vol.22 (2), p.30-34

BUDD, G. T

1995

Volltextzugriff (PDF)

Phase I/II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancer

Journal of cancer research and clinical oncology, 1999-08, Vol.125 (8-9), p.500-504

1999

Volltextzugriff (PDF)

1 – 25 von 1.580

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.340)
Mit Volltextzugriff
(1.415)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.565)
Japanisch
(113)
Russisch
(16)
Norwegisch
(2)
Französisch
(1)
Deutsch
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(699)
Life Sciences & Biomedicine
(430)
Humans
(330)
Physics
(269)
Physical Sciences
(212)
Female
(205)
Biological And Medical Sciences
(174)
Physics Of Elementary Particles And Fields
(153)
Adult
(143)
Male
(143)
Middle Aged
(141)
Animals
(135)
Oncology
(130)
Medical Sciences
(120)
High Energy Physics - Experiment
(116)
Aged
(105)
Exact Sciences And Technology
(72)
Technology
(70)
Physics, Particles & Fields
(66)
Fermilab Collider Detector
(64)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer

Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer

In search of fundamental discreteness in (2 + 1)-dimensional quantum gravity

Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study

The effective kinetic term in CDT

Semi-classical dynamical triangulations

Phase I Trial of Exisulind (Sulindac Sulfone, FGN-1) as a Chemopreventive Agent in Patients with Familial Adenomatous Polyposis

Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy

Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumors

Estrogen receptor mutations in tamoxifen-resistant breast cancer

Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706

Phase II trial of liposomal doxorubicin (Doxil®) in advanced soft tissue sarcomas

A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinoma

Interferon-γ and CXC chemokine induction by interleukin 12 in renal cell carcinoma

Amifostine and chemotherapy-related thrombocytopenia

Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma

Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study

Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma

Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial

Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trial

Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancy

Ifosfamide in the treatment of soft tissue sarcomas

Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects

Palliative chemotherapy of adult soft tissue sarcomas

Phase I/II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancer

Suchergebnisse filtern